Aspire Biopharma Holdings, Inc. (ASBP)
9.00
+0.39
(+4.53%)
USD |
NASDAQ |
Sep 10, 14:42
Aspire Biopharma Holdings Gross Profit Margin (Quarterly) : 19.49% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.49% |
| March 31, 2026 | 20.42% |
| Date | Value |
|---|---|
| December 31, 2025 | -23.26% |
| September 30, 2025 | 47.37% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -217.8% |
| Return on Invested Capital | -462.8% |
| Profit Margin (Quarterly) | -2.01K% |
| Operating Margin (Quarterly) | -3.88K% |
| Return on Net Operating Assets | -5.83K% |